4.0
13 Oct 2017
Anonymous employee
Current employee
Recommend
CEO approval
Business outlook
Pros
Autonomy in the field, good therapies,
Cons
Poor marketing materials, managers have their favorites, many people still do not know who Actelion is, hoping the J and J acquisition will help change this.